Sanare Lab Fenbendazole Success Stories

Fenbendazole (Panacur C) is a deworming medication known to have anti-cancer properties. It disrupts cancer cells’ ability to metabolize sugar, starving them. It also boosts the production of p53, a gene that keeps cancer cells in check. It has become increasingly popular amongst cancer patients after several sanare lab fenbendazole success stories.

During an 8-wk facility treatment for Aspiculuris tetraptera pinworms using the anthelminthic drug fenbendazole, human lymphoma xenografts failed to grow in C.B-17/Icr-prkdcscid/Crl (SCID) mice. We investigated whether fenbendazole alone or in combination with a sterilizable diet supplemented with additional vitamins affected tumor growth. Both fenbendazole and the supplemented vitamins had antitumor effects in our xenograft model. However, the fenbendazole-supplemented diet was not autoclaved, and vitamin concentrations may have been lower than expected.

Initial complete blood counts of all groups were similar and showed a paucity of lymphocytes, typical of SCID mice. However, at study termination, a significantly greater reduction in total white cell count and neutrophil count was observed in the fenbendazole-plus-vitamin group compared with the control group. This reduction was attributed to the effect of the dietary supplemental fenbendazole and the synergistic action of the vitamins on the cellular metabolism of the tumor. This effect could have been further enhanced by the addition of berberine, which has been shown to inhibit cancer cell proliferation and metastasis.